title: Mesenchymal bone marrow cell therapy in a mouse model of chagas disease. Where do the cells go?
abstract: BACKGROUND
  Chagas disease, resulting from infection with the parasite Trypanosoma cruzi (T. cruzi), is a major cause of cardiomyopathy in Latin America. Drug therapy for acute and chronic disease is limited. Stem cell therapy with bone marrow mesenchymal cells (MSCs) has emerged as a novel therapeutic option for cell death-related heart diseases, but efficacy of MSC has not been tested in Chagas disease.
  
  
  RESULTS
  We now report the use of cell-tracking strategies with nanoparticle labeled MSC to investigate migration of transplanted MSC in a murine model of Chagas disease, and correlate MSC biodistribution with glucose metabolism and morphology of heart in chagasic mice by small animal positron emission tomography (microPET). Mice were infected intraperitoneally with trypomastigotes of the Brazil strain of T. cruzi and treated by tail vein injection with MSC one month after infection. MSCs were labeled with near infrared fluorescent nanoparticles and tracked by an in vivo imaging system (IVIS). Our IVIS results two days after transplant revealed that a small, but significant, number of cells migrated to chagasic hearts when compared with control animals, whereas the vast majority of labeled MSC migrated to liver, lungs and spleen. Additionally, the microPET technique demonstrated that therapy with MSC reduced right ventricular dilation, a phenotype of the chagasic mouse model.
  
  
  CONCLUSIONS
  We conclude that the beneficial effects of MSC therapy in chagasic mice arise from an indirect action of the cells in the heart rather than a direct action due to incorporation of large numbers of transplanted MSC into working myocardium.
authors.affiliation: Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.lastname: Jasmin
authors.forename: Linda A
authors.initials: LA
authors.lastname: Jelicks
authors.forename: Wade
authors.initials: W
authors.lastname: Koba
authors.forename: Herbert B
authors.initials: HB
authors.lastname: Tanowitz
authors.forename: Rosalia
authors.initials: R
authors.lastname: Mendez-Otero
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Campos de Carvalho
authors.forename: David C
authors.initials: DC
authors.lastname: Spray
mesh_terms: D000818:Animals; D001682:Biological Availability; D001854:Bone Marrow Cells / Q000166:cytology; D016026:Bone Marrow Transplantation / Q000379:methods*; D002598:Chagas Cardiomyopathy / Q000473:pathology / Q000628:therapy*; D004195:Disease Models, Animal; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D051379:Mice; D009206:Myocardium / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013194:Staining and Labeling